SCHEMBL5722862

SCHEMBL5722862

COc1ccc(C(=O)Cc2ccncc2)c2cc(-c3ccccc3C(C)C)oc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 11/20 0.44
PDE4B Q07343 10/20 0.44
PDE4A P27815 8/20 0.44
PDE4C Q08493 8/20 0.44
THRB P10828 2/20 0.42
RORC P51449 2/20 0.42
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP3A4 P08684 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39
FNTA P49354 1/20 0.37
FNTB P49356 1/20 0.37
HPGDS O60760 1/20 0.37
LMNA P02545 1/20 0.36
MAPK1 P28482 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
POLB P06746 1/20 0.36
HIF1A Q16665 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5723157 0.99 PDE4D (0.43) PDE4DPDE4BPDE4APDE4CTHRB
SCHEMBL5722955 0.87 PDE4D (0.45) PDE4DPDE4BPDE4APDE4CKDM4E
Hydrochloric Acid SCHEMBL5723039 0.86 PDE4D (0.44) PDE4DPDE4BPDE4APDE4CKDM4E
SCHEMBL5722718 0.85 PDE4D (0.47) PDE4DPDE4BPDE4APDE4CALDH1A1
Hydrochloric Acid SCHEMBL5723070 0.84 PDE4D (0.47) PDE4DPDE4BPDE4APDE4CALDH1A1
SCHEMBL5723057 0.84 PDE4D (0.50) PDE4DPDE4BPDE4APDE4CCYP3A4
SCHEMBL5723020 0.82 ADRA2A (0.49) PDE4DPDE4BPDE4APDE4C
SCHEMBL5723007 0.80 KDM4E (0.45) PDE4DPDE4BPDE4APDE4CKDM4E
SCHEMBL5722904 0.79 PDE4D (0.47) PDE4DPDE4BPDE4APDE4CTHRB
SCHEMBL5722911 0.78 PDE4D (0.56) PDE4DPDE4BPDE4APDE4CKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0771794-B1 OXYGEN-CONTAINING HETEROCYCLIC COMPOUNDS KYOWA HAKKO KOGYO KK (JP) 2006-05-03 EP disclosed
US-6716987-B1 PHOSPHODIESTERASE IV INHIBITORS KYOWA HAKKO KOGYO CO., LTD. (JP) 2004-04-06 US disclosed
US-6514996-B2 Derivatives of benzofuran or benzodioxole KYOWA HAKKO KOGYO CO., LTD. (JP) 2003-02-04 US disclosed
US-20020128290-A1 DERIVATIVES OF BENZOFURAN OR BENZODIOXOLE KYOWA HAKKO KOGYO CO., LTD. (JP) 2002-09-12 US disclosed
EP-0771794-A1 OXYGEN-CONTAINING HETEROCYCLIC COMPOUNDS KYOWA HAKKO KOGYO CO., LTD. (JP) 1997-05-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020128290-A1 DERIVATIVES OF BENZOFURAN OR BENZODIOXOLE CBR1, CBR3, CYC1 PDE4D 4870/4885PDE4B 4877/4885PDE4A 4879/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.